Polaris Evidence
Pharmaceutical Manufacturing • 
North Hertfordshire, United Kingdom • 1-10 Employees
Company overview
| Headquarters | North Hertfordshire, United Kingdom |
| NAICS | 3254 |
| Keywords | Market Access, Heor, HTA, Evidence Generation, Reimbursement Strategy |
| Founded | 2021 |
| Employees | 1-10 |
Key Contact at Polaris Evidence
Kevin Lock
Founder and Director
About Polaris Evidence
I am an experienced Market Access and Health Economics professional with almost 20 years of experience in the pharmaceutical industry. My mission is to support companies in their ambition to navigate reimbursement challenges by leveraging my expertise in health technology assessment (HTA), health economics, evidence synthesis, real-world evidence (RWE), patient-reported outcomes (PRO’s) and pricing strategies including complex access agreements. I have experience in a range of therapy areas; from Oncology to Cardiometabolism, from Inflammatory Disorders affecting thousands to Rare Diseases impacting dozens. Whether you need insight to plan for and overcome future hurdles whilst in product development phases, or have an established product which is expanding into new indications, I can share my technical and strategic skills to help you achieve success.
Polaris Evidence revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Polaris Evidence has never raised funding before.
Hong Kong
Israel
United States
Singapore
Germany
Frequently asked questions
4.8
40,000 users
